Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2018 | Crucial role of the cancer nurse in managing patients on CAR T-cell therapy

Kathleen McDermott • 17 Nov 2018
UKONS 2018
General CAR-T

The importance of ensuring cancer nurses receive the essential education needed to be able to effectively manage patients on new cellular therapies cannot be underestimated. From the UK Oncology Nursing Society (UKONS) 2018 Annual Conference, in Glasgow, UK, Kathleen McDermott, RN, BSN, OCN, BMTCN, of the Dana-Farber Cancer Institute, Boston, MA, discusses the crucial role of the cancer nurse in the treatment of patients receiving CAR T-cell therapy, highlighting the importance of nurse education in managing patients on these novel therapies, as well as their role in educating patients.

More from Kathleen McDermott

2:04
Key scientific principles for nurses managing patients on CAR T-cell therapy
Kathleen McDermott • 17 Nov 2018

Related Videos

4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals